← FDA Drug Approvals (Drugs@FDA)

EPTIFIBATIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2017-11-06

Drug application

FDA Application #

ANDA205557

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPTIFIBATIDE

Generic name

Eptifibatide

Active ingredients

EPTIFIBATIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

ACCORD HLTHCARE

First approval

2017-11-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown